鼻中隔成形术患者阿片类药物处方习惯的变化。

Q1 Medicine
R. Aulet, V. Trieu, G. Landrigan, D. Millay
{"title":"鼻中隔成形术患者阿片类药物处方习惯的变化。","authors":"R. Aulet, V. Trieu, G. Landrigan, D. Millay","doi":"10.1001/jamafacial.2019.0937","DOIUrl":null,"url":null,"abstract":"Importance\nOpioid prescriptions have increased substantially over the last 2 decades, contributing to the opioid epidemic. Physician practices and legislative changes play a key role in decreasing prescription opioid use.\n\n\nObjective\nTo evaluate changes in opioid prescribing habits for patients undergoing rhinoplasty and/or septoplasty before and after the adoption of new opioid legislation.\n\n\nDesign, Setting, and Participants\nThis single-institution case-control study examined opioid prescribing habits for 80 patients who were undergoing rhinoplasty and septoplasty with or without turbinate reduction at the University of Vermont between March 2016 and May 2018. Patients were excluded if they underwent concomitant endoscopic sinus surgery or were younger than 14 years. Patients were divided by surgery date before or after legislative changes on July 1, 2017.\n\n\nExposures\nRhinoplasty and septoplasty with or without turbinate reduction.\n\n\nMain Outcomes and Measures\nPatient demographics and opioid prescriptions were recorded. Patients were evaluated if they reported pain during follow-up, called the office, or received a second prescription. The Vermont Prescription Monitoring System was queried to determine if opioid prescriptions were filled within 30 days of the procedure. The 2 groups were compared to test the hypothesis that opioid prescriptions had decreased after legislative changes.\n\n\nResults\nOf a total of 80 participants, the mean (SD) age in the before (15 women [37.5%]) and after (16 women [40.0%]) groups were 41.4 years and 40.6 years, respectively. There was a statistically significant decrease in the number of pills prescribed to the after group (17.5 to 9.7; P < .001) as well as a decrease in the morphine milligram equivalents that were prescribed (130.9 to 73.2; P < .001). There was no statistical difference in the number of postoperative telephone calls for pain, second prescriptions, or increased complaints of pain at the postoperative visit.\n\n\nConclusions and Relevance\nRecent laws in Vermont regarding opioid prescribing were implemented in 2017 to curb the ongoing opioid epidemic. Our observations of patients undergoing septoplasties and rhinoplasties found a significant reduction in opioid prescriptions. This was not associated with an increase in patient complaints about postoperative pain or the need for a second prescription after surgery. This shows that we may safely be able to decrease the number of narcotic medications that we prescribe.\n\n\nLevel of Evidence\n3.","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2019.0937","citationCount":"15","resultStr":"{\"title\":\"Changes in Opioid Prescribing Habits for Patients Undergoing Rhinoplasty and Septoplasty.\",\"authors\":\"R. Aulet, V. Trieu, G. Landrigan, D. Millay\",\"doi\":\"10.1001/jamafacial.2019.0937\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Importance\\nOpioid prescriptions have increased substantially over the last 2 decades, contributing to the opioid epidemic. Physician practices and legislative changes play a key role in decreasing prescription opioid use.\\n\\n\\nObjective\\nTo evaluate changes in opioid prescribing habits for patients undergoing rhinoplasty and/or septoplasty before and after the adoption of new opioid legislation.\\n\\n\\nDesign, Setting, and Participants\\nThis single-institution case-control study examined opioid prescribing habits for 80 patients who were undergoing rhinoplasty and septoplasty with or without turbinate reduction at the University of Vermont between March 2016 and May 2018. Patients were excluded if they underwent concomitant endoscopic sinus surgery or were younger than 14 years. Patients were divided by surgery date before or after legislative changes on July 1, 2017.\\n\\n\\nExposures\\nRhinoplasty and septoplasty with or without turbinate reduction.\\n\\n\\nMain Outcomes and Measures\\nPatient demographics and opioid prescriptions were recorded. Patients were evaluated if they reported pain during follow-up, called the office, or received a second prescription. The Vermont Prescription Monitoring System was queried to determine if opioid prescriptions were filled within 30 days of the procedure. The 2 groups were compared to test the hypothesis that opioid prescriptions had decreased after legislative changes.\\n\\n\\nResults\\nOf a total of 80 participants, the mean (SD) age in the before (15 women [37.5%]) and after (16 women [40.0%]) groups were 41.4 years and 40.6 years, respectively. There was a statistically significant decrease in the number of pills prescribed to the after group (17.5 to 9.7; P < .001) as well as a decrease in the morphine milligram equivalents that were prescribed (130.9 to 73.2; P < .001). There was no statistical difference in the number of postoperative telephone calls for pain, second prescriptions, or increased complaints of pain at the postoperative visit.\\n\\n\\nConclusions and Relevance\\nRecent laws in Vermont regarding opioid prescribing were implemented in 2017 to curb the ongoing opioid epidemic. Our observations of patients undergoing septoplasties and rhinoplasties found a significant reduction in opioid prescriptions. This was not associated with an increase in patient complaints about postoperative pain or the need for a second prescription after surgery. This shows that we may safely be able to decrease the number of narcotic medications that we prescribe.\\n\\n\\nLevel of Evidence\\n3.\",\"PeriodicalId\":14538,\"journal\":{\"name\":\"JAMA facial plastic surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1001/jamafacial.2019.0937\",\"citationCount\":\"15\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JAMA facial plastic surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/jamafacial.2019.0937\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA facial plastic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jamafacial.2019.0937","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 15

摘要

阿片类药物处方在过去二十年中大幅增加,导致阿片类药物流行。医生实践和立法变化在减少处方阿片类药物使用方面发挥关键作用。目的评价新阿片类药物立法实施前后,隆鼻和/或鼻中隔成形术患者阿片类药物处方习惯的变化。设计、环境和参与者这项单机构病例对照研究调查了2016年3月至2018年5月期间在佛蒙特大学接受鼻成形术和鼻中隔成形术(有或没有鼻甲复位)的80名患者的阿片类药物处方习惯。如果患者同时接受了内窥镜鼻窦手术或年龄小于14岁,则排除在外。患者按手术日期在2017年7月1日立法变更之前或之后进行了划分。暴露鼻成形术和鼻中隔成形术伴或不伴鼻甲复位。主要结果和测量记录患者人口统计数据和阿片类药物处方。评估患者是否在随访期间报告疼痛,是否打电话给办公室,是否接受了第二处方。询问佛蒙特州处方监测系统以确定是否在手术后30天内填写了阿片类药物处方。将这两组进行比较,以检验立法改革后阿片类药物处方减少的假设。结果80例患者中,治疗前(15例(37.5%))组和治疗后(16例(40.0%))组的平均SD年龄分别为41.4岁和40.6岁。治疗后一组服用的药片数量有统计学意义上的显著减少(17.5到9.7;P < 0.001)以及吗啡当量的减少(130.9到73.2;p < 0.001)。术后因疼痛而打电话的次数、第二处方的次数或术后就诊时疼痛投诉增加的次数均无统计学差异。佛蒙特州关于阿片类药物处方的最新法律于2017年实施,以遏制持续的阿片类药物流行。我们对接受鼻中隔成形术和鼻成形术的患者的观察发现,阿片类药物处方显著减少。这与患者对术后疼痛的抱怨或术后需要二次处方的增加无关。这表明我们可以安全地减少我们开出的麻醉药物的数量。证据水平
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Changes in Opioid Prescribing Habits for Patients Undergoing Rhinoplasty and Septoplasty.
Importance Opioid prescriptions have increased substantially over the last 2 decades, contributing to the opioid epidemic. Physician practices and legislative changes play a key role in decreasing prescription opioid use. Objective To evaluate changes in opioid prescribing habits for patients undergoing rhinoplasty and/or septoplasty before and after the adoption of new opioid legislation. Design, Setting, and Participants This single-institution case-control study examined opioid prescribing habits for 80 patients who were undergoing rhinoplasty and septoplasty with or without turbinate reduction at the University of Vermont between March 2016 and May 2018. Patients were excluded if they underwent concomitant endoscopic sinus surgery or were younger than 14 years. Patients were divided by surgery date before or after legislative changes on July 1, 2017. Exposures Rhinoplasty and septoplasty with or without turbinate reduction. Main Outcomes and Measures Patient demographics and opioid prescriptions were recorded. Patients were evaluated if they reported pain during follow-up, called the office, or received a second prescription. The Vermont Prescription Monitoring System was queried to determine if opioid prescriptions were filled within 30 days of the procedure. The 2 groups were compared to test the hypothesis that opioid prescriptions had decreased after legislative changes. Results Of a total of 80 participants, the mean (SD) age in the before (15 women [37.5%]) and after (16 women [40.0%]) groups were 41.4 years and 40.6 years, respectively. There was a statistically significant decrease in the number of pills prescribed to the after group (17.5 to 9.7; P < .001) as well as a decrease in the morphine milligram equivalents that were prescribed (130.9 to 73.2; P < .001). There was no statistical difference in the number of postoperative telephone calls for pain, second prescriptions, or increased complaints of pain at the postoperative visit. Conclusions and Relevance Recent laws in Vermont regarding opioid prescribing were implemented in 2017 to curb the ongoing opioid epidemic. Our observations of patients undergoing septoplasties and rhinoplasties found a significant reduction in opioid prescriptions. This was not associated with an increase in patient complaints about postoperative pain or the need for a second prescription after surgery. This shows that we may safely be able to decrease the number of narcotic medications that we prescribe. Level of Evidence 3.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: Facial Plastic Surgery & Aesthetic Medicine (Formerly, JAMA Facial Plastic Surgery) is a multispecialty journal with a key mission to provide physicians and providers with the most accurate and innovative information in the discipline of facial plastic (reconstructive and cosmetic) interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信